Why the Japara (ASX:JHC) share price is rocketing 23% in morning trade

The Japara Healthcare Ltd (ASX: JHC) share price is rocketing 23% higher today following a significant announcement. We take a closer look.

A drawing of a rocket follows a chart up, indicating share price lift

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Japara Healthcare Ltd (ASX: JHC) share price is rocketing in early-morning trade following the announcement of a takeover offer.

At the time of writing, the aged care provider's shares are swapping hands for 98.5 cents, up 23.1%.

Details of the offer

Investors are driving Japara shares higher after digesting the company's latest release.

In its announcement, Japara advised it has received a takeover proposal from Little Company of Mary Health Care Ltd (Calvary).

Founded in 1885, Little Company of Mary Health Care (also known as Calvary Health Care) provides community and aged care services. The group operates 14 public and private hospitals, 17 retirement and aged care facilities, and a number of community care centres throughout Australia.

The notice is an unsolicited, indicative, conditional, and non-binding proposal. Calvary plans to acquire 100% of the shareholding in Japara by way of a Scheme of Arrangement.

The indicative cash price offered to Japara shareholders is listed as $1.04 per share.

The company noted that the offer price takes into account that no dividends, distributions, or reductions in capital are paid. In addition, no material changes may occur from the date of the takeover notice. This is to ensure that the business does not significantly change in value from what Calvary has offered.

For the proposal to move forward, Japara would need to meet a number of conditions. This includes completion of due diligence, negotiation and executing the scheme arrangement, and unanimous recommendation by the board.

Japara management stated that it has not formed and view and will look into the offer along with business continuity. Trading conditions are expected to improve, and the group is waiting to hear the Australian federal government's response to the Royal Commission next month.

The Royal Commission looked into aged care quality and safety in October 2018. In March this year, the final report was released, listing 148 recommendations.

Lastly, Japara advised that it will update shareholders and the ASX in due course of the board's outcome.

About the Japara share price

The Japara share price has gained 60% in the past 12 months, and is up close to 30% year-to-date.

On valuation grounds, Japara commands a market capitalisation of around $213 million, with 267.2 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A red heart-shaped balloon floats up above the plain white ones, indicating the best shares.
Healthcare Shares

Heart tech firm's shares surge after huge capital raise

A strategic investor has also jumped on board.

Read more »

Lab technician in lab with a tray of specimens
Healthcare Shares

Has this ASX 200 stock just turned the corner after 7% surge?

Brokers think the volatile biotech share can sustain the rally this time.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »